Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A quick prediction tool for unfavourable outcome in COVID-19 inpatients: Development and internal validation.
Salto-Alejandre S, Roca-Oporto C, Martín-Gutiérrez G, Avilés MD, Gómez-González C, Navarro-Amuedo MD, Praena-Segovia J, Molina J, Paniagua-García M, García-Delgado H, Domínguez-Petit A, Pachón J, Cisneros JM. Salto-Alejandre S, et al. J Infect. 2021 Feb;82(2):e11-e15. doi: 10.1016/j.jinf.2020.09.023. Epub 2020 Sep 25. J Infect. 2021. PMID: 32987098 Free PMC article. No abstract available.
SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome.
Salto-Alejandre S, Berastegui-Cabrera J, Camacho-Martínez P, Infante-Domínguez C, Carretero-Ledesma M, Crespo-Rivas JC, Márquez E, Lomas JM, Bueno C, Amaya R, Lepe JA, Cisneros JM, Pachón J, Cordero E, Sánchez-Céspedes J; Virgen del Rocío Hospital COVID-19 Working Team. Salto-Alejandre S, et al. Sci Rep. 2021 Jun 21;11(1):12931. doi: 10.1038/s41598-021-92400-y. Sci Rep. 2021. PMID: 34155307 Free PMC article.
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection.
Pérez-Gómez A, Vitallé J, Gasca-Capote C, Gutierrez-Valencia A, Trujillo-Rodriguez M, Serna-Gallego A, Muñoz-Muela E, Jiménez-Leon MLR, Rafii-El-Idrissi Benhnia M, Rivas-Jeremias I, Sotomayor C, Roca-Oporto C, Espinosa N, Infante-Domínguez C, Crespo-Rivas JC, Fernández-Villar A, Pérez-González A, López-Cortés LF, Poveda E, Ruiz-Mateos E; Virgen del Rocío Hospital COVID-19 Working Team. Pérez-Gómez A, et al. Among authors: roca oporto c. Cell Mol Immunol. 2021 Sep;18(9):2128-2139. doi: 10.1038/s41423-021-00728-2. Epub 2021 Jul 21. Cell Mol Immunol. 2021. PMID: 34290398 Free PMC article.
Factors associated with recruitment success in the phase 2a study of aztreonam-avibactam development programme: a descriptive qualitative analysis among sites in Spain.
Jimenez-Rodriguez RM, Martín-Gutiérrez G, Jiménez-Jorge S, Rosso-Fernández CM, Tallón-Aguilar L, Roca-Oporto C, Padillo J, Luckey A, Cano A, López-Ruiz J, Gómez-Zorrilla S, Bonnín-Pascual J, Boix-Palop L, Montejo JM, Torre-Cisneros J, Cisneros JM. Jimenez-Rodriguez RM, et al. Among authors: roca oporto c. BMJ Open. 2022 Feb 3;12(2):e051187. doi: 10.1136/bmjopen-2021-051187. BMJ Open. 2022. PMID: 35115349 Free PMC article. Clinical Trial.
Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial.
Cisneros JM, Rosso-Fernández CM, Roca-Oporto C, De Pascale G, Jiménez-Jorge S, Fernández-Hinojosa E, Matthaiou DK, Ramírez P, Díaz-Miguel RO, Estella A, Antonelli M, Dimopoulos G, Garnacho-Montero J; Magic Bullet Working Group WP1. Cisneros JM, et al. Crit Care. 2019 Nov 28;23(1):383. doi: 10.1186/s13054-019-2627-y. Crit Care. 2019. PMID: 31779711 Free PMC article. Clinical Trial.
Modulation of Monocyte Activation and Function during Direct Antiviral Agent Treatment in Patients Coinfected with HIV and Hepatitis C Virus.
De Pablo-Bernal RS, Jimenez-Leon MR, Tarancon-Diez L, Gutierrez-Valencia A, Serna-Gallego A, Trujillo-Rodriguez M, Alvarez-Rios AI, Milanes-Guisado Y, Espinosa N, Roca-Oporto C, Viciana P, Lopez-Cortes LF, Ruiz-Mateos E. De Pablo-Bernal RS, et al. Antimicrob Agents Chemother. 2020 Aug 20;64(9):e00773-20. doi: 10.1128/AAC.00773-20. Print 2020 Aug 20. Antimicrob Agents Chemother. 2020. PMID: 32571815 Free PMC article.
Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?
Milanés-Guisado Y, Gutiérrez-Valencia A, Muñoz-Pichardo JM, Rivero A, Trujillo-Rodriguez M, Ruiz-Mateos E, Espinosa N, Roca-Oporto C, Viciana P, López-Cortés LF. Milanés-Guisado Y, et al. J Antimicrob Chemother. 2020 Jan 1;75(1):200-207. doi: 10.1093/jac/dkz421. J Antimicrob Chemother. 2020. PMID: 31617904
Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1-2, a Randomized Controlled Clinical Trial.
Cordero E, Roca-Oporto C, Bulnes-Ramos A, Aydillo T, Gavaldà J, Moreno A, Torre-Cisneros J, Montejo JM, Fortun J, Muñoz P, Sabé N, Fariñas MC, Blanes-Julia M, López-Medrano F, Suárez-Benjumea A, Martinez-Atienza J, Rosso-Fernández C, Pérez-Romero P; TRANSGRIPE 1–2 Study Group. Cordero E, et al. Clin Infect Dis. 2017 Apr 1;64(7):829-838. doi: 10.1093/cid/ciw855. Clin Infect Dis. 2017. PMID: 28362949 Clinical Trial.
Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: study protocol for a multicenter, randomized, controlled clinical trial.
Martinez-Atienza J, Rosso-Fernández C, Roca C, Aydillo TA, Gavaldà J, Moreno A, Montejo JM, Torre-Cisneros J, Fariñas MC, Fortun J, Sabé N, Muñoz P, Blanes-Julia M, Suárez-Benjumea A, López-Medrano F, Pérez-Romero P, Cordero E; TRANSGRIPE 1-2 Study Group. Martinez-Atienza J, et al. Trials. 2014 Aug 28;15:338. doi: 10.1186/1745-6215-15-338. Trials. 2014. PMID: 25168918 Free PMC article. Clinical Trial.
20 results